Accelerant Holdings (NYSE: ARX), the specialty insurance risk exchange being bought by Thoma Bravo, reported third-quarter 2026 Exchange Written Premium of $1.33 billion on 12 November 2026, up 27%. Accelerant guidance for 2026 was last set in May, because the company said on 13 August 2026 that it would give none for the full year. Fintechbits read the 8-K Accelerant Holdings filed with the SEC on 13 May 2026 and found full-year 2026 guidance of at least $5.2 billion of Exchange Written Premium and at least $285 million of adjusted EBITDA. Nine months of delivery make the premium target a stretch and the EBITDA target comfortable.

Accelerant Guidance Against Nine Months of Delivery

Accelerant Holdings’ 13 May 2026 outlook also set a floor of $2.3 billion for third-party direct written premium and said $276 million of the EBITDA target would come from fee-based businesses. For the second quarter the Accelerant guidance was premium of $1.27 billion to $1.32 billion and adjusted EBITDA of $60 million to $66 million, and the Form 8-K of 13 August 2026 shows $1,322.3 million and $93.1 million delivered.

Against those floors, Accelerant has booked $3,790.6 million of Exchange Written Premium over nine months, 73% of its $5.2 billion floor, and $230.5 million of adjusted EBITDA, 81% of its $285 million floor. Reaching the premium floor needs $1,409.4 million in the fourth quarter, which is 6% above the third quarter and above every quarter of 2025 and 2026 in the published figures. The trailing-twelve-month premium of $4.88 billion implies about $1.09 billion for the fourth quarter of 2025, so the floor needs growth of roughly 29%, against 27% in the third quarter.

The EBITDA half of the Accelerant guidance is easier, since reaching $285 million needs $54.5 million in the fourth quarter, below each of the $66.1 million, $93.1 million and $71.3 million reported for the first three.

Retention, Loss Ratio and Underwriting Slipped in Q3

Accelerant’s third-quarter release shows growth outpacing quality: net revenue retention fell to 116% from 135% a year earlier, and the gross loss ratio rose to 56.8% from 50.1%. The Underwriting segment, the part of the business that books net earned premiums and claims costs, lost $13.2 million of adjusted EBITDA against a $17.2 million profit in the third quarter of 2025.

Adjusted EBITDA still rose 9% to $71.3 million, with a margin of 25.4% against about 29% a year earlier, because the fee businesses grew. Chief Financial Officer Linda S. Huber put fee-based adjusted EBITDA at $84.5 million, up 75%. Members reached 340 from 265, with 26 added in the quarter, and third-party direct written premium made up 49% of volume against 32%.

The Thoma Bravo Price Sits Below the 2025 IPO

Thoma Bravo has agreed to buy Accelerant Holdings for $20.25 per share in cash, 75 cents below the $21.00 at which Accelerant priced its IPO on 24 July 2025. The preliminary proxy statement filed on 30 October 2026 puts the price at a 49% premium to the $13.61 close on 12 August 2026, the last trading day before signing. The 40-day go-shop period expired on 22 September 2026 without an alternative proposal, so the Accelerant guidance sits beside a price that drew no higher offer.

Accelerant would owe the Thoma Bravo buyer $136.5 million in most termination cases, while the buyer would owe Accelerant $295.8 million in some. Jeff Radke, chairman and chief executive, and co-founders Chris Lee-Smith and Frank O’Neill are listed with an Altamont Capital Partners affiliate and a Thoma Bravo vehicle as expected shareholders of the buyer’s parent.

Why Accelerant Guidance Still Matters After the Takeover

Accelerant guidance matters because the $20.25 price is fixed, so the quarter cannot change what shareholders receive, but it can change whether the deal faces pressure. A premium target that needs a record quarter, an underwriting segment in loss and falling retention give shareholders little reason to expect a higher bid after a go-shop that drew none, and the Accelerant guidance leaves no fresh numbers to argue otherwise.

The 340 members are managing general agents, the segment in which Fintechbits covered Great Hill Partners’ stake in Aurenity on 5 September 2026 and the Kalepa Series B on 9 November 2026. For them, the sale brings a technology-focused owner, and it was the fee business that carried the quarter. For rivals, the weak spots are the underwriting book and retention, not growth. For regulators, timing depends on insurance approvals, and Accelerant’s merger agreement pays shareholders $0.00333 per share a day after the other conditions are met until those approvals arrive.

Frequently asked questions

Will Accelerant guidance be updated after the third quarter?

No. Accelerant Holdings said on 12 November 2026 that no guidance will follow for the fourth quarter or full year of 2026 because of the pending Thoma Bravo transaction, and it held no earnings call. Accelerant guidance from 13 May 2026 therefore remains the last published.

What price is Thoma Bravo paying for Accelerant?

Thoma Bravo’s affiliates will pay Accelerant Holdings shareholders $20.25 per share in cash, an enterprise value of more than $4 billion. Accelerant expects completion during the first half of 2027, subject to a shareholder vote and regulatory approvals.

How did Accelerant’s third-quarter results compare with a year earlier?

Accelerant’s Exchange Written Premium rose 27% to $1,329.6 million, and adjusted EBITDA rose to $71.3 million from $65.5 million. Net loss was $9.2 million against $1,367.0 million a year earlier, which carried a one-time IPO charge, and the gross loss ratio rose to 56.8% from 50.1%.

What to Watch Next

Accelerant’s definitive proxy statement will set the shareholder meeting date, and approval needs two-thirds of the votes cast. Insurance regulatory approvals decide when the daily payment to shareholders stops, and no new Accelerant guidance will arrive to frame it. The fourth-quarter premium figure, if Accelerant reports it before closing, shows whether the $1.41 billion hurdle was cleared.